Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
InnoPCV
- Development stage
- Phase 1
- Lead developer
- Innovac Therapeutics
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
InnoPCV is an individualized neo-antigen mRNA cancer vaccine encapsulated in lipid nanoparticles. It is designed as a therapeutic cancer vaccine to stimulate the immune system against advanced malignant solid neoplasms. The drug works as an immunostimulant, aiming to enhance the body's immune response to tumor-specific neoantigens. Developed by Innovac Therapeutics, InnoPCV is currently being evaluated in early phase 1 clinical trials for use in combination with PD-1 inhibitors for patients with advanced solid tumors[1][2][3][4]. Its primary modality is as an mRNA-based therapeutic vaccine delivered via lipid nanoparticles.
- Other names
- Neo-antigen mRNA vaccine - Innovac Therapeutics
Beyond the preview
Go deeper on InnoPCV.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InnoPCV.